Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

• Status: Completed
• Trial end date: 2004-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheba Medical Center
• Treatments: Naltrexone

Criteria

Inclusion Criteria:

• Diagnosis of OCD

• Treatment with SSRI for at least 10 weeks with no response

Exclusion Criteria:

• Suffering from any medical condition

• treatment with opiates

• chronic use of drugs

• Hepatitis or other liver related diseases

• Incapability to sign an informed consent